|
Development Portfolio::
Within a span of 5 years, the major achievements to the credit of the Torrent R&D Centre are the development of world class fermentation technology for Pen-G, synthesis of Omeprazole, Sparfloxacin, Nicorandil, Lamotrigine, Sertraline, Sildenafil Citrate, Repaglinide, Rosiglitazone, Clopidogrel, Sibutramine and Cerivastatin and the introduction of low dose combination of Lisinopril and Hydrochlorothiazide(Listril Plus/Forte), matching international quality standards. This rational combination was specifically formulated keeping in mind the needs of Indian patients.
First Time Introduction by the Centre
:
- Fluconazole 0.3% Eye Drops for the first time in the world.
- Esomeprazole (20,40mg) Multi Unit Particulate System (Pellets compressed in the form of tablet) for the first time in India.
- Rosiglitazoe 2mg/4mg Immediate Release + Metformin 500mg Sustanded - Release Dual Retard Technology launched in the form of Inlay Tablet for the first time of India.
- Few Non-Conventional Dosage Forms Developed
| Dilzem CD (Diltiazem) |
Controlled Release Pallets |
| Alprax Plus (Alprazolam SR + Sertraline) |
Sustained Release + Immediate Release Bi Component Capsule |
| Lamitor DT (Lamotrigine) |
Dispersible Tablet |
| Calcigard (Nifedipine) |
Soft Gelatin Capsule |
| Valparin Alkalets (Sodium Valproate) |
Enteric Coated Tablet |
| Valparin Chrono (Sodium Valproate) |
Sustained Release Matrix Tablet |
| Fegem (Iron Polymaltose Complex) |
Chewable Tablet |
| Droxil Ready (Cefadroxil) |
Ready To Use Suspension |
| Dilzem Inj (Diltiazem) |
Life Saving Injectable |
| Nikoran IV (Nicorandil) |
Lyophilized Injectable |
| Nexpro (Esomeprazole) |
Pellets compressed in Tablet |
| Enselin MF (Rosiglitazone IR+ Metformin SR) |
Dual Retard Technology in form of Inlay Tablet |
|
